<DOC>
	<DOCNO>NCT00356850</DOCNO>
	<brief_summary>To evaluate azithromycin tear concentration instillation one drop one three T1225 concentration ( 0.5 % , 1 % 1.5 % ) evaluate ocular safety .</brief_summary>
	<brief_title>Ocular Pharmacokinetics After Single Drop Instillation T1225 0.5 , 1 , 1.5 % 91 Healthy Volunteers</brief_title>
	<detailed_description>The aim present study compare azithromycin tear ocular concentration single instillation three different T1225 concentration order determine early azithromycin tear concentration ass T1225 concentration , allow high azithromycin tear concentration , 24 hour single instillation .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Eye Infections , Bacterial</mesh_term>
	<criteria>Male/female age 18 45 year ; Written inform consent ; Healthy volunteer without subjective ocular symptom ; Corrected visual acuity &gt; = 6/10 ; Registered national register healthy volunteer Ocular trauma , infection inflammation within last 3 month ; Conjunctival hyperaemia ( score &gt; = 2 ) ; Folliculopapillary conjunctivitis ( score &gt; = 2 ) ; Topical ocular treatment within last month ; Ocular surgery , include LASIK PRK , within last 12 month ; Other ocular laser within last 3 month ; Zithromax® Azadose® within last 3 month ; Medication study ( except : paracetamol , contraceptive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>